| P50 | author | Josef Penninger | Q1674391 |
| P2093 | author name string | Lin Lu | |
| | Gavin Y Oudit | |
| | Tong Zhou | |
| | Ding-Liang Zhu | |
| | Ping-Jin Gao | |
| | Bei Song | |
| | Hai-Yan Jin | |
| | Jiu-Chang Zhong | |
| | Ying-Le Xu | |
| | Zhen-Zhou Zhang | |
| | Qian-Hui Shang | |
| P2860 | cites work | Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes | Q84114676 |
| | Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression | Q24295246 |
| | ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation | Q28585962 |
| | Involvement of NADPH oxidase in age-associated cardiac remodeling | Q33882656 |
| | ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production | Q34302600 |
| | Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit | Q35152116 |
| | Mice with cardiac overexpression of peroxisome proliferator-activated receptor γ have impaired repolarization and spontaneous fatal ventricular arrhythmias | Q35672091 |
| | Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress | Q36445023 |
| | Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension | Q36824736 |
| | A Lectin-EGF antibody promotes regulatory T cells and attenuates nephrotoxic nephritis via DC-SIGN on dendritic cells | Q36835243 |
| | Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice | Q36948376 |
| | Defective peroxisomal proliferators activated receptor gamma activity due to dominant-negative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice | Q37201578 |
| | Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation | Q37318895 |
| | Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis | Q37636881 |
| | Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation | Q37764239 |
| | Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases | Q38074786 |
| | Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress | Q41783370 |
| | Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction | Q43266255 |
| | Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo | Q43913705 |
| | Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways | Q45084828 |
| | Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats | Q45101312 |
| | ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice. | Q46024676 |
| | Signal transduction involved in CTGF-induced production of chemokines in mesangial cells | Q46044974 |
| | Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. | Q51772425 |
| | Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. | Q53173814 |
| | Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling. | Q54306904 |
| | Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. | Q54395386 |
| | Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. | Q54648878 |
| | Proteome changes in the myocardium of experimental chronic diabetes and hypertension | Q63684377 |
| P304 | page(s) | 229 | |
| P577 | publication date | 2013-09-25 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice | |
| P478 | volume | 11 | |